F. Morinet

1.8k total citations
53 papers, 930 citations indexed

About

F. Morinet is a scholar working on Infectious Diseases, Dermatology and Epidemiology. According to data from OpenAlex, F. Morinet has authored 53 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Infectious Diseases, 17 papers in Dermatology and 11 papers in Epidemiology. Recurrent topics in F. Morinet's work include Parvovirus B19 Infection Studies (35 papers), Dermatological and COVID-19 studies (16 papers) and Virus-based gene therapy research (9 papers). F. Morinet is often cited by papers focused on Parvovirus B19 Infection Studies (35 papers), Dermatological and COVID-19 studies (16 papers) and Virus-based gene therapy research (9 papers). F. Morinet collaborates with scholars based in France, Switzerland and Greece. F. Morinet's co-authors include Y Pérol, Isabelle Vassias, Jon-Duri Tratschin, Alison Thomas, Brian B. Rudkin, A.F. Prigent, C. Pallier, Serge Fichelson, F Ferchal and Olivier Meyer and has published in prestigious journals such as The Lancet, Journal of Virology and Transplantation.

In The Last Decade

F. Morinet

50 papers receiving 893 citations

Peers

F. Morinet

DERMA

PPCH

GENET

HEMAT

Marcelo de Souza Fernandes Pereira Nepal

Jacqueline F. Fryer United Kingdom

H. T. Weiland Netherlands

M. J. Anderson United Kingdom

Guy Burtonboy Belgium

Gunnar Schalasta Germany

Lourdes Tamayo‐Sánchez Vietnam

H. J. Girschick Germany

Nílceo Schwery Michalany Brazil

Adriana María Porro Brazil

Marcelo de Souza Fernandes Pereira Nepal

F. Morinet

704 ×1.1

443 ×1.1

DERMA

226 ×1.5

PPCH

141 ×1.0

GENET

83 ×0.6

HEMAT

Citations per year, relative to F. Morinet F. Morinet (= 1×) peers Marcelo de Souza Fernandes Pereira

Countries citing papers authored by F. Morinet

Since Specialization

Citations

This map shows the geographic impact of F. Morinet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Morinet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Morinet more than expected).

Fields of papers citing papers by F. Morinet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Morinet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Morinet. The network helps show where F. Morinet may publish in the future.

Co-authorship network of co-authors of F. Morinet

This figure shows the co-authorship network connecting the top 25 collaborators of F. Morinet. A scholar is included among the top collaborators of F. Morinet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Morinet. F. Morinet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morinet, F., et al.. (2017). Hypoxia inducible factor one alpha and human viral pathogens. Current Research in Translational Medicine. 65(1). 7–9. 3 indexed citations

Chiche, Laurent, A. Ghali, Stéphane Delliaux, et al.. (2016). Le syndrome de fatigue chronique : une nouvelle maladie ?. La Revue de Médecine Interne. 37(12). 811–819. 8 indexed citations

Servant‐Delmas, Annabelle & F. Morinet. (2016). Update of the human parvovirus B19 biology. Transfusion Clinique et Biologique. 23(1). 5–12. 25 indexed citations

Larroche, C., et al.. (2002). Spontaneous Resolution of Hemophagocytic Syndrome Associated with Acute Parvovirus B19 Infection and Concomitant Epstein-Barr Virus Reactivation in an Otherwise Healthy Adult. European Journal of Clinical Microbiology & Infectious Diseases. 21(10). 739–742. 24 indexed citations

Anglicheau, Dany, Alexandre Lautrette, Catherine Scieux, et al.. (2002). Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis. Transplantation Proceedings. 34(7). 2826–2827. 2 indexed citations

Pillet, Sylvie & F. Morinet. (2002). Parvovirus B19 and erythroid cells. Pathologie Biologie. 50(5). 349–356. 4 indexed citations

Morinet, F., et al.. (2000). Molecular Biology of Erythroviruses. PubMed. 4. 123–132. 1 indexed citations

Vassias, Isabelle, Alison Thomas, A.F. Prigent, et al.. (1999). Possible Interactions between the NS-1 Protein and Tumor Necrosis Factor Alpha Pathways in Erythroid Cell Apoptosis Induced by Human Parvovirus B19. Journal of Virology. 73(10). 8762–8770. 131 indexed citations

Raguin, G, et al.. (1997). Low prevalence of active parvovirus B19 infection in HIV-infected patients. European Journal of Clinical Microbiology & Infectious Diseases. 16(10). 760–762. 9 indexed citations

10.

Ville, Y., F. Brivet, Marianne Leruez, et al.. (1995). Fetal-Maternal Hydrops Syndrome in Human Parvovirus Infection. Fetal Diagnosis and Therapy. 10(3). 204–206. 9 indexed citations

11.

Oksenhendler, Éric, et al.. (1994). Primary central nervous system malignant non–Hodgkin's lymphomas from HIV‐infected and non‐infected patients:expression of cellular surface proteins and Epstein‐Barr viral markers. Neuropathology and Applied Neurobiology. 20(3). 243–252. 34 indexed citations

12.

Pallier, C., et al.. (1994). Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell line as demonstrated by in situ hybridization. Journal of General Virology. 75(6). 1475–1478. 20 indexed citations

13.

Alain, Sophie, et al.. (1993). Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutation within the gene UL97. Molecular and Cellular Probes. 7(6). 487–495. 20 indexed citations

14.

Morinet, F., et al.. (1993). Trans-activation of the long terminal repeat of human immunodeficiency virus type 1 by the parvovirus B19 NS1 gene product. Journal of General Virology. 74(9). 2011–2014. 32 indexed citations

15.

Kanavaros, Panagiotis, J Mikol, János Németh, et al.. (1993). Primary T-Cell Malignant Lymphoma of the Central Nervous System. Pathology - Research and Practice. 189(1). 93–98. 13 indexed citations

16.

Tchernia, Gil, et al.. (1993). Diamond Blackfan anaemia: apparent relapse due to B19 parvovirus. European Journal of Pediatrics. 152(3). 209–210. 11 indexed citations

17.

Bader‐Meunier, Brigitte, et al.. (1992). Neutropénie auto-immune et infection à parvovirus B19.. 49(4). 397–397. 3 indexed citations

18.

Morinet, F., A.M. Couroucé, Francis Galibert, & Y Pérol. (1991). The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test. Journal of Virological Methods. 32(1). 21–30. 13 indexed citations

19.

Morinet, F., L d'Auriol, Jon-Duri Tratschin, & Francis Galibert. (1989). Expression of the Human Parvovirus B19 Protein Fused to Protein A in Escherichia coli: Recognition By IgM and IgG Antibodies in Human Sera. Journal of General Virology. 70(11). 3091–3097. 26 indexed citations

20.

Coulombel, Laure, F. Morinet, F Miélot, et al.. (1989). PARVOVIRUS INFECTION, LEUKAEMIA, AND IMMUNODEFICIENCY. The Lancet. 333(8629). 101–102. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact